1. Home
  2. ENTA vs EWCZ Comparison

ENTA vs EWCZ Comparison

Compare ENTA & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • EWCZ
  • Stock Information
  • Founded
  • ENTA 1995
  • EWCZ 2004
  • Country
  • ENTA United States
  • EWCZ United States
  • Employees
  • ENTA N/A
  • EWCZ N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • EWCZ Package Goods/Cosmetics
  • Sector
  • ENTA Health Care
  • EWCZ Consumer Discretionary
  • Exchange
  • ENTA Nasdaq
  • EWCZ Nasdaq
  • Market Cap
  • ENTA 245.4M
  • EWCZ 294.0M
  • IPO Year
  • ENTA 2013
  • EWCZ 2021
  • Fundamental
  • Price
  • ENTA $9.31
  • EWCZ $5.89
  • Analyst Decision
  • ENTA Buy
  • EWCZ Buy
  • Analyst Count
  • ENTA 3
  • EWCZ 7
  • Target Price
  • ENTA $19.67
  • EWCZ $7.64
  • AVG Volume (30 Days)
  • ENTA 114.1K
  • EWCZ 718.1K
  • Earning Date
  • ENTA 11-25-2024
  • EWCZ 11-14-2024
  • Dividend Yield
  • ENTA N/A
  • EWCZ N/A
  • EPS Growth
  • ENTA N/A
  • EWCZ 62.57
  • EPS
  • ENTA N/A
  • EWCZ 0.23
  • Revenue
  • ENTA $71,960,000.00
  • EWCZ $223,500,000.00
  • Revenue This Year
  • ENTA N/A
  • EWCZ $0.81
  • Revenue Next Year
  • ENTA $5.14
  • EWCZ $4.02
  • P/E Ratio
  • ENTA N/A
  • EWCZ $25.09
  • Revenue Growth
  • ENTA N/A
  • EWCZ 2.42
  • 52 Week Low
  • ENTA $8.51
  • EWCZ $4.80
  • 52 Week High
  • ENTA $17.80
  • EWCZ $16.07
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 28.86
  • EWCZ 37.35
  • Support Level
  • ENTA $10.84
  • EWCZ $5.38
  • Resistance Level
  • ENTA $10.89
  • EWCZ $6.14
  • Average True Range (ATR)
  • ENTA 0.49
  • EWCZ 0.63
  • MACD
  • ENTA -0.19
  • EWCZ -0.25
  • Stochastic Oscillator
  • ENTA 18.18
  • EWCZ 14.46

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About EWCZ European Wax Center Inc.

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.

Share on Social Networks: